@article {CARVALHO2811, author = {MARIA ISABEL CARVALHO and RODOLFO BIANCHINI and JUDIT FAZEKAS-SINGER and INA HERRMANN and IRENE FLICKINGER and JOHANN G. THALHAMMER and ISABEL PIRES and ERIKA JENSEN-JAROLIM and FELISBINA L. QUEIROGA}, title = {Bidirectional Regulation of COX-2 Expression Between Cancer Cells and Macrophages}, volume = {38}, number = {5}, pages = {2811--2817}, year = {2018}, publisher = {International Institute of Anticancer Research}, abstract = {Background/Aim: Our aim was to investigate the crosstalk between tumor and immune cells (M2 macrophages) and its effects on cyclo-oxygenase-2 (COX2) regulation in canine mammary tumors (CMT). Materials and Methods: Sh1b CMT cells and human BT474 mammary or HT29 colon cancer cells were co-cultured with canine peripheral blood mononuclear cells (PBMCs) or with macrophage-like differentiated THP1 monocytes (dTHP1). Intracellular COX2 expression by PBMCs, dTHP1 and cancer cells was evaluated by flow cytometry. Results: Co-culturing of Sh1b and canine PBMCs induced COX2 overexpression in CMT cells. In turn, COX2 expression by PBMCs, mostly CD68+ macrophages, was attenuated by co-culture with Sh1b (p=0.0001). In accordance, co-culture with dTHP1 prompted intracellular production of COX2 in both Sh1b CMT cells and HT29 human colon cancer cells and reduced production of COX2 in BT474 human mammary cancer cells. The intracellular COX2 expression from dTHP1 decreased when treated with conditioned medium from cultured Sh1b and HT29 cancer cells. Conclusion: Bidirectional COX2 regulation between cancer and monocytes/macrophages might shape a tolerogenic tumor microenvironment in CMT.}, issn = {0250-7005}, URL = {https://ar.iiarjournals.org/content/38/5/2811}, eprint = {https://ar.iiarjournals.org/content/38/5/2811.full.pdf}, journal = {Anticancer Research} }